NIOPAM Side Effects

6600921-5 | Arteriosclerosis Coronary Artery, Cardiac Arrest, Hepatic Congestion, Pulmonary Congestion, Respiratory Arrest
on Feb 16, 2010 Female patient from UNITED KINGDOM , weighting 138.9 lb, was diagnosed with computerised tomogram and was treated with Niopam (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis coronary artery, cardiac arrest (What is cardiac arrest?), hepatic congestion, pulmonary congestion, respiratory arrest. Niopam dosage: . During the same period patient was treated with GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ASPIRIN (Dispersible) (View Aspirin Review and Aspirin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), CLOMIPRAMINE HCL (View Clomipramine Hcl Review and Clomipramine Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

5321019-2 | Anaphylactic Reaction
Patient was taking Niopam (View Usage). Patient had the following side effects: anaphylactic reaction on May 04, 2007 from UNITED KINGDOM Additional patient health information: Female patient , weighting 154.3 lb, was diagnosed with arteriovenous fistula site complication and. Niopam dosage: . During the same period patient was treated with ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), EPOGEN (View Epogen Review and Epogen Label ), CO DYDRAMOL (View Co-dydramol Review and Co-dydramol Label ), KETOVITE /00479801/ (View Ketovite /00479801/ Review and Ketovite /00479801/ Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

5306967-1 | Dermatitis Exfoliative
Adverse event was reported on Apr 19, 2007 by a Female patient taking Niopam (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 54 years of age, After Niopam was administered, patient had the following side effects: dermatitis exfoliative. During the same period patient was treated with ATROVENT (View Atrovent Review and Atrovent Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), SYMBICORT (View Symbicort Review and Symbicort Label ). Patient was hospitalized.

5289295-2 | Anaphylactic Reaction, Arteriosclerosis Coronary Artery, Cardio-respiratory Arrest, Contrast Media Reaction, Convulsion
on Mar 30, 2007 Female patient from UNITED KINGDOM , weighting 154.3 lb, was diagnosed with arteriovenous fistula site complication and was treated with Niopam (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, arteriosclerosis coronary artery, cardio-respiratory arrest, contrast media reaction, convulsion. Niopam dosage: . During the same period patient was treated with ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), EPOGEN (View Epogen Review and Epogen Label ), CO DYDRAMOL (View Co-dydramol Review and Co-dydramol Label ), KETOVITE /00479801/ (View Ketovite /00479801/ Review and Ketovite /00479801/ Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).


5269436-3 | Anaphylactic Reaction
on Mar 12, 2007 Female patient from UNITED KINGDOM , 75 years of age, weighting 154.3 lb, was treated with Niopam (View Usage). Patient had the following side effects: anaphylactic reaction. Niopam dosage: .

5113693-0 | Anaphylactic Reaction
Patient was taking Niopam (View Usage). After Niopam was administered, patient had the following side effects: anaphylactic reaction on Jun 09, 2006 from UNITED KINGDOM Additional patient health information: Female patient , weighting 143.3 lb, was diagnosed with arteriovenous fistula site complication and. Niopam dosage: . During the same period patient was treated with ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), EPOGEN (View Epogen Review and Epogen Label ), CO DYDRAMOL (View Co-dydramol Review and Co-dydramol Label ), KETOVITE /00479801/ (View Ketovite /00479801/ Review and Ketovite /00479801/ Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

5095952-3 | Muscular Weakness, Rash
Adverse event was reported on Aug 29, 2006 by a Female patient taking Niopam (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 34 years of age, Patient experienced the following unwanted or unexpected effects: muscular weakness, rash (What is rash?). During the same period patient was treated with THYROXINE (View Thyroxine Review and Thyroxine Label ), STEROIDS (View Steroids Review and Steroids Label ).

5085119-7 | Anaphylactic Reaction
on Jun 09, 2006 Female patient from UNITED KINGDOM , weighting 143.3 lb, was diagnosed with arteriovenous fistula site complication and was treated with Niopam (View Usage). Patient had the following side effects: anaphylactic reaction. Niopam dosage: . During the same period patient was treated with ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), EPOGEN (View Epogen Review and Epogen Label ), CO DYDRAMOL (View Co-dydramol Review and Co-dydramol Label ), KETOVITE /00479801/ (View Ketovite /00479801/ Review and Ketovite /00479801/ Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

5051003-8 | Anaphylactic Reaction, Cardiac Arrest
on Jul 05, 2006 Male patient from UNITED KINGDOM , 45 years of age, was diagnosed with percutaneous coronary intervention and was treated with Niopam (View Usage). After Niopam was administered, patient had the following side effects: anaphylactic reaction, cardiac arrest (What is cardiac arrest?). Niopam dosage: . During the same period patient was treated with IOHEXOL (View Iohexol Review and Iohexol Label ), BIVALIRUDIN (View Bivalirudin Review and Bivalirudin Label ).

4947985-2 | Bile Duct Necrosis, Blood Creatinine Increased, Cardio-respiratory Arrest, Cyanosis, Diffuse Alveolar Damage, Jaundice, Lymphopenia, Nephritis
Patient was taking Niopam (View Usage). Patient experienced the following unwanted or unexpected effects: bile duct necrosis, blood creatinine increased, cardio-respiratory arrest, cyanosis, diffuse alveolar damage, jaundice (What is jaundice?), lymphopenia, nephritis on Mar 14, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 46 years of age, . Niopam dosage: .